BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11592955)

  • 1. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine.
    Llinás MT; López R; Rodríguez F; Roig F; Salazar FJ
    Am J Physiol Renal Physiol; 2001 Nov; 281(5):F975-82. PubMed ID: 11592955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal changes induced by a cyclooxygenase-2 inhibitor during normal and low sodium intake.
    Rodríguez F; Llinás MT; González JD; Rivera J; Salazar FJ
    Hypertension; 2000 Aug; 36(2):276-81. PubMed ID: 10948090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cyclooxygenase-2-derived metabolites and nitric oxide in regulating renal function.
    Llinás MT; Rodríguez F; Moreno C; Salazar FJ
    Am J Physiol Regul Integr Comp Physiol; 2000 Nov; 279(5):R1641-6. PubMed ID: 11049846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclooxygenase-2 in the prolonged regulation of renal function.
    Roig F; Llinás MT; López R; Salazar FJ
    Hypertension; 2002 Nov; 40(5):721-8. PubMed ID: 12411468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide and cyclooxygenase-2 in regulating the renal hemodynamic response to norepinephrine.
    López R; Llinas MT; Roig F; Salazar FJ
    Am J Physiol Regul Integr Comp Physiol; 2003 Feb; 284(2):R488-93. PubMed ID: 12388442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
    Catella-Lawson F; McAdam B; Morrison BW; Kapoor S; Kujubu D; Antes L; Lasseter KC; Quan H; Gertz BJ; FitzGerald GA
    J Pharmacol Exp Ther; 1999 May; 289(2):735-41. PubMed ID: 10215647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prostaglandins in the renal response to calcium infusion.
    Lahera V; Fiksen-Olsen MJ; Romero JC
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F1096-9. PubMed ID: 2330974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal eicosanoids and renal hemodynamics in early borderline hypertension.
    Lebel M; Grose JH
    Clin Invest Med; 1991 Dec; 14(6):525-34. PubMed ID: 1794206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct role of intrarenal cyclooxygenase-1/2 in chronic unilateral renal ischemia.
    Tokuyama H; Hayashi K; Matsuda H; Kubota E; Honda M; Okubo K; Ozawa Y; Saruta T
    Nephron; 2002 Sep; 92(1):183-91. PubMed ID: 12187101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans.
    Isenring P; Lebel M; Falardeau P; Grose JH
    Prostaglandins Leukot Essent Fatty Acids; 1996 Jan; 54(1):59-63. PubMed ID: 8992495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
    Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
    Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs.
    Cowley AW; Lohmeier TE
    Hypertension; 1979; 1(6):549-58. PubMed ID: 396248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Effects of Cyclooxygenase Inhibition When Nitric Oxide Synthesis Is Reduced and Angiotensin II Levels Are Enhanced.
    López R; Llinás MT; Salazar E; Salazar FJ
    J Cardiovasc Pharmacol; 2015 May; 65(5):465-72. PubMed ID: 25945864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
    Opay AL; Mouton CR; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of prostaglandin inhibition during increases in renal venous pressure.
    Fiksen-Olsen MJ; Romero JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F525-9. PubMed ID: 2012205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ; Horacek V; Bäcker A; Vaneckova I; Heller J
    Kidney Blood Press Res; 2004; 27(1):10-7. PubMed ID: 14583658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit.
    Prévot A; Mosig D; Martini S; Guignard JP
    Pediatr Res; 2004 Feb; 55(2):254-60. PubMed ID: 14605244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal prostaglandin formation and pain perception following thoracotomy: a role for cyclooxygenase-2.
    McCrory C; Fitzgerald D
    Chest; 2004 Apr; 125(4):1321-7. PubMed ID: 15078741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cyclooxygenase-2 inhibition by nimesulide in man.
    Cullen L; Kelly L; Connor SO; Fitzgerald DJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.